Gene and MicroRNA Perturbations of Cellular Response to Pemetrexed Implicate Biological Networks and Enable Imputation of Response in Lung Adenocarcinoma-Reference-Cited by-同舟云学术

Gene and MicroRNA Perturbations of Cellular Response to Pemetrexed Implicate Biological Networks and Enable Imputation of Response in Lung Adenocarcinoma

Published:2018-01-15 Issue:1 Volume:8 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Gamazon Eric R.^ORCID,Trendowski Matthew R.,Wen Yujia,Wing Claudia,Delaney Shannon M.,Huh Won,Wong Shan,Cox Nancy J.,Dolan M. Eileen^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-017-19004-3.pdf

Reference62 articles.

1. Chan, B. A. & Hughes, B. G. Targeted therapy for non-small cell lung cancer: current standards and the promise of the future. Transl Lung Cancer Res 4, 36–54, https://doi.org/10.3978/j.issn.2218-6751.2014.05.01 (2015).

2. Dammeijer, F. et al. Efficacy of Tumor Vaccines and Cellular Immunotherapies in Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis. J Clin Oncol 34, 3204–3212, https://doi.org/10.1200/JCO.2015.66.3955 (2016).

3. Bibby, A. C. et al. Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment. Eur Respir Rev 25, 472–486, https://doi.org/10.1183/16000617.0063-2016 (2016).

4. Genova, C. et al. Pemetrexed for the treatment of non-small cell lung cancer. Expert Opin Pharmacother 14, 1545–1558, https://doi.org/10.1517/14656566.2013.802774 (2013).

5. Grosso, F. & Scagliotti, G. V. Systemic treatment of malignant pleural mesothelioma. Future Oncol 8, 293–305, https://doi.org/10.2217/fon.12.14 (2012).

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Growth of A549 Cell Line is Inhibited by Pemetrexed Through Up-regulation of hsa-MiR-320a Expression;Advanced Biomedical Research;2024-06

2. Long non-coding RNA terminal differentiation-induced non-coding RNA regulates cisplatin resistance of choroidal melanoma by positively modulating extracellular signal-regulated kinase 2 via sponging microRNA-19b-3p;Bioengineered;2022-01-22

3. Antifolate-based anticancer drugs;New Strategies Targeting Cancer Metabolism;2022

4. A Review of Small-Molecule Inhibitors of One-Carbon Enzymes: SHMT2 and MTHFD2 in the Spotlight;ACS Pharmacology & Translational Science;2021-03-01

5. Genetically regulated expression underlies cellular sensitivity to chemotherapy in diverse populations;Human Molecular Genetics;2021-02-01